Patents by Inventor Gary T. Wang

Gary T. Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems and methods for communications regarding loan collateral
    Patent number: 12148030
    Abstract: Systems, methods, and non-transitory computer-readable storage media are provided. A central server receives collateral data and applies a set of collateral analysis rules thereto to identify a problem. The applying includes accessing, from a remote data source, supplemental data related to the collateral data, and detecting one or more differences exceeding discrepancy tolerances between the collateral data and the supplemental data. The central server generates a notification including descriptions of the problem and the collateral data, and a navigation link to access more information from a source of problem information related to the collateral data. The central server transmits the notification to a remote computing device based upon a remote computing device destination address.
    Type: Grant
    Filed: April 18, 2023
    Date of Patent: November 19, 2024
    Assignee: FEDERAL HOME LOAN MORTGAGE CORPORATION (FREDDIE MAC)
    Inventors: Annette M. Best, Donald Rosenthal, Ferdinand T. Wang, Gary M. Skinner, Adrienne B. Lyne
  • METHODS OF CONTROLLING PLANT PATHOGENS
    Publication number: 20240215582
    Abstract: The present invention is directed to methods of controlling oomycetes comprising applying one or more cervinomycins. The present invention is further directed to methods of controlling particular fungi comprising applying one or more cervinomycins.
    Type: Application
    Filed: December 21, 2023
    Publication date: July 4, 2024
    Inventors: Julia Crane, Nicole Higgs, Gary T Wang, Christine Kraus, Sara Parker, Qingyao Shou, Francisco Romero Millan, William Weldon, Jose Maria Sanchez Lopez
  • Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
    Patent number: 11897864
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Grant
    Filed: October 7, 2022
    Date of Patent: February 13, 2024
    Assignees: AbbVie Inc., Genentech, Inc., The Walter and Eliza Hall Institute of Medical Research
    Inventors: Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa A. Hasvold, Laura Hexamer, Aaron R. Kunzer, Xiaohong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Gary T. Wang, Le Wang, Xilu Wang, Michael D. Wendt, Robert Mantei, Todd M. Hansen
  • APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
    Publication number: 20240043404
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Application
    Filed: September 6, 2023
    Publication date: February 8, 2024
    Applicants: AbbVie Inc., Genentech, Inc., The Walter and Eliza Hall Institute of Medical Research
    Inventors: Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa A. Hasvold, Laura Hexamer, Aaron R. Kunzer, Xiaohong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Gary T. Wang, Le Wang, Xilu Wang, Michael D. Wendt, Robert Mantei, Todd M. Hansen
  • APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
    Publication number: 20230143532
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Application
    Filed: October 7, 2022
    Publication date: May 11, 2023
    Applicants: AbbVie Inc., Genentech, Inc., The Walter and Eliza Hall Institute of Medical Research
    Inventors: Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa A. Hasvold, Laura Hexamer, Aaron R. Kunzer, Xiaohong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Gary T. Wang, Le Wang, Xilu Wang, Michael D. Wendt, Robert Mantei, Todd M. Hansen
  • Methods of controlling pests using terpendoles
    Patent number: 11497214
    Abstract: The present invention is directed to a method of controlling a pest comprising applying an effective amount of one or more terpendoles to the pest or an area in need of pest control. The present invention is further directed to a method of controlling a pest comprising applying an effective amount of one or more compounds having the following chemical structure to the pest or an area in need of pest control.
    Type: Grant
    Filed: June 24, 2020
    Date of Patent: November 15, 2022
    Assignee: VALENT BIOSCIENCES LLC
    Inventors: Deanna Branscome, Daniel F. Heiman, Jose Maria Sanchez Lopez, Joseph H. Lustig, Gary T. Wang, Daniel C Leep
  • APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
    Publication number: 20220315555
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Application
    Filed: November 3, 2021
    Publication date: October 6, 2022
    Applicants: AbbVie Inc., Genentech, Inc., The Walter and Eliza Hall Institute of Medical Research
    Inventors: Milan BRUNCKO, Hong DING, George A. DOHERTY, Steven W. ELMORE, Lisa A. HASVOLD, Laura HEXAMER, Aaron R. KUNZER, Xiaohong SONG, Andrew J. SOUERS, Gerard M. SULLIVAN, Zhi-Fu TAO, Gary T. WANG, Le WANG, Xilu WANG, Michael D. WENDT, Robert MANTEI, Todd M. HANSEN
  • APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
    Publication number: 20210221789
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Application
    Filed: August 27, 2020
    Publication date: July 22, 2021
    Inventors: Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa A. Hasvold, Laura Hexamer, Aaron R. Kunzer, Xiaohong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Gary T. Wang, Le Wang, Xilu Wang, Michael D. Wendt, Robert Mantei, Todd M. Hansen
  • Tolypocladium album strain
    Patent number: 10945443
    Abstract: A novel fungal strain of Tolypocladium album (synonym Chaunopycnis alba) is disclosed that has enhanced toxicity against insects and mites. This novel Tolypocladium album strain is capable of producing terpendoles A, C, I, J, K, N, O and P through fermentation and does not produce nalanthalide.
    Type: Grant
    Filed: September 25, 2018
    Date of Patent: March 16, 2021
    Assignee: VALENT BIOSCIENCES LLC
    Inventors: Maria de los Angeles Vinuesa Navarro, Jose Maria Sanchez Lopez, Deanna Branscome, Emily E. Brazil, Rebecca Dickenson, Daniel F. Heiman, Gary T. Wang, Zuoxing Zheng, Daniel C Leep
  • METHODS OF CONTROLLING PESTS USING TERPENDOLES
    Publication number: 20200352169
    Abstract: The present invention is directed to a method of controlling a pest comprising applying an effective amount of one or more terpendoles to the pest or an area in need of pest control. The present invention is further directed to a method of controlling a pest comprising applying an effective amount of one or more compounds having the following chemical structure to the pest or an area in need of pest control.
    Type: Application
    Filed: June 24, 2020
    Publication date: November 12, 2020
    Inventors: Deanna Branscome, Daniel F. Heiman, Jose Maria Sanchez Lopez, Joseph H. Lustig, Gary T. Wang
  • Methods of controlling pests using terpendoles
    Patent number: 10729135
    Abstract: The present invention is directed to a method of controlling a pest comprising applying an effective amount of one or more terpendoles to the pest or an area in need of pest control. The present invention is further directed to a method of controlling a pest comprising applying an effective amount of one or more compounds having the following chemical structure to the pest or an area in need of pest control.
    Type: Grant
    Filed: September 25, 2018
    Date of Patent: August 4, 2020
    Assignee: VALENT BIOSCIENCES LLC
    Inventors: Deanna Branscome, Daniel F. Heiman, Jose Maria Sanchez Lopez, Joseph H. Lustig, Gary T. Wang
  • APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
    Publication number: 20200231566
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Application
    Filed: August 30, 2019
    Publication date: July 23, 2020
    Inventors: Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa A. Hasvold, Laura Hexamer, Aaron R. Kunzer, Xiaohong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Gary T. Wang, Le Wang, Xilu Wang, Michael D. Wendt, Robert Mantei, Todd M. Hansen
  • (S)-abscisic acid derivatives for improving plant stress tolerance
    Patent number: 10314307
    Abstract: The present invention is directed to the treatment of crop plants with 3?-methyl-(S)-abscisic acid, 3?-propargyl-(S)-abscisic acid, and/or salts thereof in order to improve the plants' environmental stress tolerance.
    Type: Grant
    Filed: May 19, 2016
    Date of Patent: June 11, 2019
    Assignee: VALENT BIOSCIENCES LLC
    Inventors: Franklin Paul Silverman, Gary T. Wang, Kimberly Ann Falco, Derek D. Woolard, Dale O. Wilson, Jr., Daniel C. Leep, Gregory D. Venburg
  • 3?-substituted-abscisic acid derivatives
    Patent number: 10299476
    Abstract: The invention relates to a novel class of (S)-3?-substituted-abscisic acid derivatives and (±)-3?-substituted-abscisic acid derivatives, and methods of synthesizing the derivatives.
    Type: Grant
    Filed: September 5, 2017
    Date of Patent: May 28, 2019
    Assignee: VALENT BIOSCIENCES LLC
    Inventors: Gary T. Wang, Daniel F. Heiman, Gregory D. Venburg, Eiki Nagano, Marci Surpin, Joseph H. Lustig
  • APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
    Publication number: 20190119247
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Application
    Filed: May 30, 2018
    Publication date: April 25, 2019
    Inventors: Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa A. Hasvold, Laura Hexamer, Aaron R. Kunzer, Xiaohong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Gary T. Wang, Le Wang, Xilu Wang, Michael D. Wendt, Robert Mantei, Todd M. Hansen
  • METHODS OF CONTROLLING PESTS USING TERPENDOLES
    Publication number: 20190098900
    Abstract: The present invention is directed to a method of controlling a pest comprising applying an effective amount of one or more terpendoles to the pest or an area in need of pest control. The present invention is further directed to a method of controlling a pest comprising applying an effective amount of one or more compounds having the following chemical structure to the pest or an area in need of pest control.
    Type: Application
    Filed: September 25, 2018
    Publication date: April 4, 2019
    Inventors: Deanna Branscome, Daniel F. Heiman, Jose Maria Sanchez Lopez, Joseph H. Lustig, Gary T. Wang
  • NOVEL TOLYPOCLADIUM ALBUM STRAIN
    Publication number: 20190098904
    Abstract: A novel fungal strain of Tolypocladium album (synonym Chaunopycnis alba) is disclosed that has enhanced toxicity against insects and mites. This novel Tolypocladium album strain is capable of producing terpendoles A, C, I, J, K, N, O and P through fermentation and does not produce nalanthalide.
    Type: Application
    Filed: September 25, 2018
    Publication date: April 4, 2019
    Inventors: Maria de los Angeles Vinuesa Navarro, Jose Maria Sanchez Lopez, Deanna Branscome, Emily E. Brazil, Rebecca Dickenson, Daniel F. Heiman, Gary T. Wang, Zuoxing Zheng
  • 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID POLYMORPHS
    Publication number: 20180282260
    Abstract: The present invention is directed to 1-aminocyclopropane-1-carboxylic acid polymorphs and agricultural compositions thereof.
    Type: Application
    Filed: March 29, 2018
    Publication date: October 4, 2018
    Inventors: Mitsunobu Kawamura, Daniel F. Heiman, Kosuke Takebayashi, Gary T. Wang
  • APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
    Publication number: 20180251426
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Application
    Filed: October 13, 2017
    Publication date: September 6, 2018
    Inventors: Milan Bruncko, Yujia Dai, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa Hasvold, Laura Hexamer, Aaron R. Kunzer, Robert A. Mantei, Chang H. Park, Cheol-Min Park, Andrew M. Petros, Xiaohong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Gary T. Wang, Le Wang, Xilu Wang, Michael D. Wendt, William J. McClellan
  • (S)-abscisic acid derivatives for enhanced grape coloration
    Patent number: 9877480
    Abstract: The present invention is directed to the treatment of grapes with 3?-methyl-(S)-abscisic acid, 3?-propargyl-(S)-abscisic acid, and/or salts thereof in order to enhance the color of the grapes.
    Type: Grant
    Filed: May 19, 2016
    Date of Patent: January 30, 2018
    Assignee: Valent Biosciences LLC
    Inventors: Derek D. Woolard, Gary T. Wang, Rick Hopkins, Daniel C. Leep, Gregory D. Venburg